SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chun Lin Chen, Daksha Desai-Krieger, Stephan Ortiz, Majid Kerolous, Harold M. Wright, Parviz Ghahramani, A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State, American Journal of Therapeutics, 2015, 22, 5, e130

    CrossRef

  2. 2
    Matt Shirley, Paul L. McCormack, Perindopril/Amlodipine (Prestalia®): A Review in Hypertension, American Journal of Cardiovascular Drugs, 2015, 15, 5, 363

    CrossRef

  3. 3
    Atsushi Sakima, Toshihiro Kita, Seigo Nakada, Naoto Yokota, Noboru Tamaki, Takuma Etoh, Toru Shimokubo, Kazuo Kitamura, Shuichi Takishita, Yusuke Ohya, Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers, Clinical and Experimental Hypertension, 2014, 36, 1, 40

    CrossRef

  4. 4
    David E. Kemp, Managing the side effects associated with commonly used treatments for bipolar depression, Journal of Affective Disorders, 2014, 169, S34

    CrossRef

  5. 5
    Harold Bays, Dingliang Zhu, Helmut Schumacher, Single-Pill Combination of Telmisartan and Hydrochlorothiazide: Studies and Pooled Analyses of Earlier Hypertension Treatment, High Blood Pressure & Cardiovascular Prevention, 2014, 21, 2, 119

    CrossRef

  6. 6
    Raymond V. Oliva, George L. Bakris, Sympathetic Activation in Resistant Hypertension: Theory and Therapy, Seminars in Nephrology, 2014, 34, 5, 550

    CrossRef

  7. 7
    Steen Neldam, Helmut Schumacher, Sverre E. Kjeldsen, Joel M. Neutel, Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension, Current Medical Research and Opinion, 2014, 30, 9, 1715

    CrossRef

  8. 8
    James Brian Byrd, George Bakris, Kenneth Jamerson, The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension, Current Hypertension Reports, 2014, 16, 3

    CrossRef

  9. 9
    Xiaojuan Li, Wendy Camelo Castillo, Til Stürmer, Virginia Pate, Christine L. Gray, Ross J. Simpson, Soko Setoguchi, Laura C. Hanson, Michele Jonsson Funk, Use of Combination Antihypertensive Therapy Initiation in Older Americans without Prevalent Cardiovascular Disease, Journal of the American Geriatrics Society, 2014, 62, 9
  10. 10
    Claudio Borghi, Stefano Omboni, Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update, Expert Review of Cardiovascular Therapy, 2014, 12, 9, 1055

    CrossRef

  11. 11
    Claudio Borghi, Federico Maria Verardi, Ilenia Pareo, A possible role for hydrochlorothiazide (HCTZ) as "enhancer" of zofenopril activity at the tissue level, Cardiovascular System, 2013, 1, 1, 6

    CrossRef

  12. 12
    Shunjing Ding, Jin Liu, Qiang Fu, Ying Zheng, Clinical effects of combined olmesartan medoxomil and amlodipine on clinic and ambulatory blood pressure in elderly patients with resistant hypertension, Archives of Gerontology and Geriatrics, 2013, 57, 3, 423

    CrossRef

  13. 13
    S. H. Hong, J. Wang, J. Tang, Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy, American Journal of Hypertension, 2013, 26, 7, 879

    CrossRef

  14. 14
    S. Neldam, B. Dahlöf, W. Oigman, H. Schumacher, Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals, International Journal of Clinical Practice, 2013, 67, 9
  15. 15
    Seiji Umemoto, Toshio Ogihara, Hiromi Rakugi, Masayasu Matsumoto, Kazuo Kitagawa, Kazuyuki Shimada, Jitsuo Higaki, Sadayoshi Ito, Hiromichi Suzuki, Yasuo Ohashi, Takao Saruta, Masunori Matsuzaki, Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial, Hypertension Research, 2013, 36, 12, 1088

    CrossRef

  16. 16
    Qi-Fang Huang, Chang-Sheng Sheng, Yan Li, Gen-Shan Ma, Qiu-Yan Dai, Ji-Guang Wang, Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension, Drugs in R&D, 2013, 13, 2, 109

    CrossRef

  17. 17
    C. L. Alviar, S. Devarapally, G. N. Nadkarni, J. Romero, A. M. Benjo, F. Javed, B. Doherty, H. Kang, S. Bangalore, F. H. Messerli, Efficacy and Safety of Dual Calcium Channel Blockade for the Treatment of Hypertension: A Meta-Analysis, American Journal of Hypertension, 2013, 26, 2, 287

    CrossRef

  18. 18
    Steen Neldam, Dingliang Zhu, Helmut Schumacher, Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy, International Journal of Hypertension, 2013, 2013, 1

    CrossRef

  19. 19
    Steven M. Smith, Epidemiology, Prognosis, and Treatment of Resistant Hypertension, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 10
  20. 20
    Alexandros Briasoulis, George Bakris, Initial single-pill combination therapy for cardiovascular risk factor management, Journal of Hypertension, 2013, 31, 8, 1537

    CrossRef

  21. 21
    Karly P. Garnock-Jones, Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy, American Journal of Cardiovascular Drugs, 2013, 13, 2, 141

    CrossRef

  22. 22
    Jessica Barochiner, José Alfie, Lucas S. Aparicio, Paula E. Cuffaro, Marcelo A. Rada, Margarita S. Morales, Carlos R. Galarza, Gabriel D. Waisman, Prevalence and Clinical Profile of Resistant Hypertension among Treated Hypertensive Subjects, Clinical and Experimental Hypertension, 2013, 35, 6, 412

    CrossRef

  23. 23
    K. Yayehd, F. Damorou, R. Akakpo, T. Tchérou, N.W. N’Da, S. Pessinaba, L. Belle, A. Johnson, Prévalence de l’hypertension artérielle et description de ses facteurs de risque à Lomé (Togo) : résultats d’un dépistage réalisé dans la population générale en mai 2011, Annales de Cardiologie et d'Angéiologie, 2013, 62, 1, 43

    CrossRef

  24. 24
    Ludwin Ley, Helmut Schumacher, Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients), Current Medical Research and Opinion, 2013, 29, 1, 41

    CrossRef

  25. You have free access to this content25
    Sverre E. Kjeldsen, Helmut Schumacher, Steen Neldam, Robert M. Guthrie, Telmisartan/Hydrochlorothiazide Combination Therapy for the Treatment of Hypertension: A Pooled Analysis in Older and Younger Patients, The Journal of Clinical Hypertension, 2013, 15, 6
  26. 26
    Viktor L. Nagy, Twenty-Four-Hour Ambulatory Blood Pressure Reduction with a Perindopril/Amlodipine Fixed-Dose Combination, Clinical Drug Investigation, 2013, 33, 7, 469

    CrossRef

  27. 27
    Anna Solini, José A. García-Donaire, Luis M. Ruilope, Combination Therapy in Hypertension, Current Cardiovascular Risk Reports, 2012, 6, 4, 291

    CrossRef

  28. 28
    N. Martell Claros, M.A. Prieto Díaz, Cuándo y por qué iniciar el tratamiento farmacológico con doble terapia, SEMERGEN - Medicina de Familia, 2012, 38, 7, 445

    CrossRef

  29. 29
    Yao Potchoo, Edem Goe-Akue, Findibe Damorou, Barima Massoka, Datouda Redah, Innocent P. Guissou, Effect of Antihypertensive Drug Therapy on the Blood Pressure Control among Hypertensive Patients Attending Campus’ Teaching Hospital of Lome, Togo, West Africa, Pharmacology & Pharmacy, 2012, 03, 02, 214

    CrossRef

  30. 30
    Samir G Mallat, What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?, Cardiovascular Diabetology, 2012, 11, 1, 32

    CrossRef

  31. 31
    Naohiko Ueno, Yoshiko Satou, The Enhanced Effect of Atenolol on Hypertension in Metabolic Syndrome, Metabolic Syndrome and Related Disorders, 2011, 9, 5, 369

    CrossRef

  32. 32
    Javier Garjón, Ana Azparren, José J Elizondo, Idoia Gaminde, Mª José Ariz, Juan Erviti, Luis Carlos Saiz, Monotherapy versus combination therapy used as first-line therapy for primary hypertension, The Cochrane Library,